SBFMSunshine Biopharma, Inc.

$6M

Q1 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$5M+3890.4% YoY

Gross Profit

$2M37.4% margin

Operating Income

-$2M-37.4% margin

Net Income

-$2M-34.8% margin

EPS (Diluted)

$-154.51

QoQ Revenue Growth

+24.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$27M

Total Liabilities

$8M

Stockholders' Equity

$19M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$122,645	+3890.4%
Gross Profit	$2M	$62,800	+2810.8%
Operating Income	-$2M	-$1M	-49.5%
Net Income	-$2M	-$1M	-37.7%

SBFM Q1 2023 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena